Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormones and menopause: pro.

J J Amy1

  • 1Department of Gynaecology, Andrology and Obstetrics, Academisch Ziekenhuis, Vrije Universiteit Brussel, Belgium. cgynpnb@az.vub.ac.be

Acta Clinica Belgica
|January 10, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GnRH antagonist in the adjuvant treatment of a recurrent ovarian granulosa cell tumor: a case report.

Gynecologic oncology·2005
Same author

A persistently recurring peri-urethral soft tissue lesion of the vulva.

Pathology, research and practice·2005
Same author

Low-grade endometrial stromal sarcoma treated with the aromatase inhibitor letrozole.

Gynecologic oncology·2004
Same author

[Major gynecologic surgery: birth, first steps, and blossoming].

Revue medicale de Bruxelles·2004
Same author

A 10-year follow-up after Kegel pelvic floor muscle exercises for genuine stress incontinence.

BJU international·2000
Same author

The seven surgeons of King's: a fable by Aesop.

British journal of obstetrics and gynaecology·1999
Same journal

MEFV variants as phenotypic modifiers in ankylosing spondylitis: a genetic interaction analysis with HLA-B27.

Acta clinica Belgica·2026
Same journal

What Europe should (not) learn from the new Dietary Guidelines for Americans.

Acta clinica Belgica·2026
Same journal

Real-world evidence on In-hospital statin use and mortality in geriatric patients.

Acta clinica Belgica·2026
Same journal

TKI-associated proteinuria and nephrotic syndrome: a narrative review with clinical illustration in radio-iodine-refractory thyroid cancer.

Acta clinica Belgica·2026
Same journal

A decade of insulin pump therapy in a Belgian paediatric diabetes centre: longitudinal outcomes and evolving practices.

Acta clinica Belgica·2026
Same journal

Pneumococcal vaccination in Belgian adults: a practical translation of the 2025 Superior Health Council guidelines.

Acta clinica Belgica·2026
See all related articles

Hormone replacement therapy (HRT) offers significant quality of life improvements for menopausal women with minimal risks when tailored individually. Concerns about cardiovascular disease and breast cancer are often exaggerated compared to other lifestyle risk factors.

Area of Science:

  • Reproductive Endocrinology
  • Women's Health
  • Clinical Pharmacology

Background:

  • Public perception of hormone replacement therapy (HRT) has been negatively influenced by media coverage of randomized trials.
  • Concerns regarding cardiovascular disease and breast cancer risks associated with HRT have been widely publicized, leading to user anxiety.
  • The relative risks of breast cancer associated with lifestyle factors (e.g., early menarche, obesity, alcohol) were not adequately communicated, skewing public and professional opinion.

Purpose of the Study:

  • To provide an objective reassessment of the risks and benefits of hormone replacement therapy (HRT).
  • To contextualize HRT risks against other known risk factors for conditions like breast cancer.
  • To offer evidence-based recommendations for optimal HRT use in postmenopausal women.

Related Experiment Videos

Main Methods:

  • Review and synthesis of available evidence on hormone replacement therapy (HRT) outcomes.
  • Comparative analysis of HRT risks versus risks associated with lifestyle and reproductive factors.
  • Evaluation of different HRT administration routes and their impact on risk profiles.

Main Results:

  • Individually tailored HRT initiated around menopause improves quality of life with negligible risk.
  • Parenteral estrogen administration is preferred; intrauterine progestin minimizes breast malignancy risk.
  • Cardiovascular disease and stroke risks are not significantly increased in women aged 50-59 using HRT.

Conclusions:

  • HRT, when appropriately prescribed, offers substantial benefits for menopausal women.
  • The risks associated with HRT are often disproportionately emphasized compared to lifestyle-related risks.
  • Personalized HRT regimens, considering route of administration and patient history, optimize safety and efficacy.